|
NUS1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.63810000031984E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.232600E-04 |
| Normal-vs-Stage2 |
5.496000E-02 |
| Normal-vs-Stage3 |
1.84089999999415E-06 |
| Normal-vs-Stage4 |
1.8480999997017E-07 |
| Stage1-vs-Stage2 |
8.395800E-01 |
| Stage1-vs-Stage3 |
6.265900E-02 |
| Stage1-vs-Stage4 |
1.580320E-02 |
| Stage2-vs-Stage3 |
4.402000E-01 |
| Stage2-vs-Stage4 |
3.162600E-01 |
| Stage3-vs-Stage4 |
6.999000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.82645999999842E-05 |
| Normal-vs-AfricanAmerican |
9.50299949842304E-10 |
| Normal-vs-Asian |
2.346200E-02 |
| Caucasian-vs-AfricanAmerican |
7.752500E-04 |
| Caucasian-vs-Asian |
6.605800E-01 |
| AfricanAmerican-vs-Asian |
4.691600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.31679999816026E-08 |
| Normal-vs-Female |
3.599800E-03 |
| Male-vs-Female |
4.991700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.239400E-04 |
| Normal-vs-Age(41-60Yrs) |
1.994870E-04 |
| Normal-vs-Age(61-80Yrs) |
1.91409999994452E-06 |
| Normal-vs-Age(81-100Yrs) |
9.026100E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.188400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.745200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.108800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.522400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.113600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.039400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.787000E-01 |
| Normal-vs-Grade 2 |
3.950300E-02 |
| Normal-vs-Grade 3 |
5.69600000499548E-09 |
| Normal-vs-Grade 4 |
3.32950000903054E-10 |
| Grade 1-vs-Grade 2 |
4.310000E-01 |
| Grade 1-vs-Grade 3 |
1.816400E-02 |
| Grade 1-vs-Grade 4 |
2.016800E-03 |
| Grade 2-vs-Grade 3 |
3.760600E-04 |
| Grade 2-vs-Grade 4 |
1.50204000000098E-05 |
| Grade 3-vs-Grade 4 |
5.674500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.204000E-01 |
| Normal-vs-ccB subtype |
6.81739997787645E-10 |
| ccA subtype-vs-ccB subtype |
3.26950000406612E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.043600E-04 |
| Normal-vs-N1 |
5.282700E-03 |
| N0-vs-N1 |
1.078410E-01 |
|
|
